Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1984-4-12
pubmed:abstractText
It has been suggested that the serum of infants with ABO hemolytic disease contains hematin which might interfere with bilirubin binding to albumin, increasing the risk of kerincterus. Using the horseradish peroxidase assay, we investigated this possibility. Cord serum from healthy term infants was enriched with bilirubin to a bilirubin/albumin molar ratio of 0.6, and then varying amounts of hematin were added. Hematin had a significant adverse effect on bilirubin binding when present in half to equimolar ratios with bilirubin. This high concentration of hematin does not appear to be present in serum from infants with ABO hemolytic disease and no difference was seen when comparing the dilute and the undilute peroxidase assays. These data suggest that hematin can alter bilirubin binding in neonatal serum but is not os physiologic importance for infants with ABO-isoimmune hemolysis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0006-3126
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
53-7
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
The effect of hematin on bilirubin binding in bilirubin-enriched neonatal cord serum.
pubmed:publicationType
Journal Article